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Abstract
Interleukin-2 (IL-2) exercises an array of biological effects on many cells including the functional activation of cells of the
innate immune response. Heterophils, the avian equivalent of the neutrophil, function as professional phagocytes to aid in
regulation of innate host defenses. The objective of the present studies was to examine the effects of recombinant chicken IL-2
(rChIL-2) on functional activities of heterophils from chickens during the first 3 weeks after hatch. Peripheral blood heterophils
were isolated and incubated with either COS cell-derived rChIL-2 or supernatants from mock-transfected COS cells. rChIL-2
had no effect on the functional activities of heterophils from day-of-hatch chickens, but significantly increased the phagocytosis
and bactericidal activity of heterophils from 7- and 14-day-old chickens. rChIL-2 induced no direct stimulation of the
respiratory burst by heterophils, but primed heterophils from 7- and 14-day-old birds for an enhanced respiratory burst in
response to phorbol ester stimulation. Lastly, rChIL-2 had neither direct nor priming effects on heterophil degranulation. The
enhancing effects on heterophil functional activity by rChIL-2 were abated by a neutralizing anti-chicken IL-2 mAb and were
therefore specific for this cytokine. These results show that rChIL-2 can directly activate chicken heterophils to exert effector
functions, and that heterophil activation by rChIL-2 is also an age-dependent event.q2002 Elsevier Science Ltd. All rights reserved.
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1. Introduction
The common characteristic of both the innate and
acquired immune systems is their ability to regulate
their function through the prompt production of
cytokines.
Heterophils are the primary effector cells of the
acute innate host defenses to bacterial infections in
poultry. Studies have shown a direct relationship
between the high susceptibility of neonatal poultry
to infectious diseases and the functional immaturity
of poultry heterophils during the first week post-
hatch [1–5]. Likewise, the avian immune cells
produce few or no cytokines during the first week
post-hatch, further increasing the susceptibility of
domestic poultry to infections [4]. Because of this
deficiency in the functional ontogeny of the avian
innate and acquired immune responses, there is a
probable veterinary application for potentiating
avian host defenses during the first week of life.
Cytokines are vital constituents in the regulation of
immunity and inflammation [5]. The use of cyto-
kines and cytokine genes as vaccine adjuvants,
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immunotherapeutics, and immune response modu-
lators for treatment or prevention of cancer and
infectious diseases are important focal points of
current clinical research in both the human and
veterinary medicine [6–10]. IL-2 is one such cytokine
that is being investigated in both tumor and infectious
disease immunology because it plays an active role in
the activation and maintenance of both acquired and
innate immune defenses [11–23]. Classically, IL-2
has been shown to be mitogenic for T lymphocytes,
but has subsequently been found to stimulate growth-
promoting activity in B cells and NK cells [11–14].
More recently, IL-2 has been shown to activate human
monocytes and neutrophils to generate tumoricidal
and microbicidal activities, produce an oxidative
burst, and secrete several cytokines and bioactive
lipids [15–23].
The recent cloning and sequencing of the avian IL-
2 homologue has stimulated discussion on the use of
this regulatory cytokine as either a vaccine adjuvant
or immune modulating molecule in poultry [26,27].
Since the heterophil is a critical cell in the develop-
ment of innate responses in poultry and is responsive
to various cytokines, the objective of the present
studies was to examine the effects of recombinant
chicken IL-2 (rChIL-2) on the functional activation of
heterophils from chickens during the first 3 weeks
after hatch.
2. Materials and methods
2.1. Experimental animals
One-day-old Leghorn chicks (HyLine W-36w)
were obtained from a commercial hatchery and
randomly placed in electrically heated commercial
brooder batteries (Petersime Incubator Co., Gettys-
burg, OH) located within a biological hazard isolation
unit on the research farm of the College of Veterinary
Medicine, Texas A&M University. Chicks were
provided ad libitum access to water and a balanced
unmedicated corn–soybean ration. The feed ration
contained or exceeded the levels of critical nutrients
recommended by the National Research Council [24].
2.2. Bacteria
A poultry isolate of S. enteritidis (SE), obtained
from the National Veterinary Services Laboratory,
Ames, IA, was used in the phagocytosis assays. A
stock culture of SE was prepared in sterile phosphate-
buffered saline and adjusted to a concentration of
109 cfu/ml using a spectrophotometer with a 625 nm
reference wavelength.
2.3. Heterophil agonists
Phorbol myristate acetate (PMA; 1 mg/ml) was
dissolved in dimethyl sulfoxide (DMSO) and stored at
220 8C as a stock solution until used in the
experiments. The final concentration of DMSO in
the assay media did not exceed 0.5% (v/v). Opsonized
zymosan (OZ) was prepared by boiling zymosan A in
0.9% saline for 20 min and washing twice with saline.
The unopsonized zymosan (20 mg/ml) was suspended
in pooled normal chicken serum, opsonized for
30 min at 39 8C on a rotary shaker, washed twice
with Ca2þ, Mg2þ-free HBSS, and stored at 4 8C in
HBSS (20 mg/ml) until used.
2.4. Isolation of peripheral blood heterophils
Heterophils were isolated from the peripheral
blood of Leghorn chickens as described previously
[25]. Briefly, disodium ethylenediaminetetraacetic
acid (EDTA)-anti-coagulated blood was mixed with
1% methylcellulose (25 cp; Sigma Chemical Co., St
Louis, MO) as a 1.5:1 ratio and centrifuged at 25g for
5 min. The serum and buffy coat layers were retained
and suspended in Ca2þ, Mg2þ-free Hanks’ balanced
salt solution (HBSS, 1:1; Sigma Chemical Co., St
Louis, MO). This suspension was layered over a
discontinuous Ficoll-Hypaque gradient (specific grav-
ity 1.077 over specific gravity 1.119; Sigma Chemical
Co., St Louis, MO). The gradient was then centrifuged
at 250g for 20–25 min. After centrifugation, the
1.077/1.119 interface and 1.119 band containing the
heterophils were collected and washed twice in RPMI
1640 medium and resuspended in fresh RPMI 1640.
Cell viability was determined by trypan blue exclu-
sion. The purity of the heterophil suspensions was
assessed by microscopic examination of Hema-3
stained (Curtin Mathison Scientific, Dallas, TX)
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cytospin (Shandon Scientific, Pittsburgh, PA) smears.
Heterophil preparations obtained by this method were
typically .95% pure and .95% viable. The cell
concentration was adjusted to 4 £ 106 heterophils/ml
and stored on ice until used.
2.5. Production of recombinant ChIL-2
Supernatants of COS cells containing rChIL-2
were produced as described [26]. Briefly, primers
were designed to ChIL-2 cDNA clones isolated by
Sundick and Gill-Dixon [27]. COS-7 cells were
routinely grown in DMEM containing 10% FCS,
1% non-essential amino acids, 1% L-glutamine, 1 U/
ml penicillin, and 1 mg/ml streptomycin at 37 8C, 5%
CO2, and passaged using standard conditions [26].
Cells were cultured at 5 £ 105 ml21 for 18–24 h at
37 8C, 5% CO2, and washed twice with PBS. Five
milliliters of serum-free media was then added
containing 7.5 mg/ml DNA (pCIneo containing
rchIL-2 or no plasmid), 258 mg/ml cholorquine and
600 mg/ml DEAE–dextran. Flasks were incubated for
3 h at 37 8C, 5% CO2. The transfection media was
then removed and cells washed once with PBS. PBS
containing 10% dimethylsulfoxide was then added for
2 min, removed and replaced with 5 ml growth
medium. After 24 h growth at 37 8C, 5% CO2, growth
media was replaced with serum-free DMEM. The
cells were then incubated for 72 h, following which
supernatant was collected and stored at 4 8C prior to
use in the assays.
2.6. Experimental design
Chicken heterophils (4 £ 106 ml21) were incu-
bated with various concentrations of COS cell-derived
rChIL-2 for 2 h at 39 8C on a rotary shaker in a 5%
CO2 incubator. The heterophils were then used to
perform the functional assays described below. All
functional assays were conducted at least three times
and triplicate readings were recorded for each assay.
Control assays were performed using heterophils
incubated with mock-transfected COS cell
supernatants.
The anti-coagulated blood from 50 chickens was
pooled and the heterophils were isolated from each
treatment group as described above. Each heterophil
functional assay was conducted four times over a
2-month period with pooled heterophils (heterophils
pooled from 50 chickens for each preparation; i.e. 200
total chickens were used as cell donors). At least three
replicates were conducted for each heterophil func-
tional assay with the heterophils from each pool of
chickens. The data from these four repeated exper-
iments were pooled for presentation and statistical
analysis.
2.7. mAb neutralization of rChIL-2
To confirm the specificity of the rChIL-2-inducing
activities, the rChIL-2 was preincubated (1:1) with
mouse anti-rChIL-2 neutralizing mAb (4F12) [28] on
a rocker platform for 1 h at room temperature. After
this incubation, the suspension was filtered through a
YM100 ultrafiltration membrane (Amicon Corpor-
ation, Danvers, MA) to remove any rChIL-2-antibody
complexes and/or unbound IgG molecules before use
in any assays. As controls, rChIL-2 was also
pretreated with a preimmune mouse IgG as described
for the anti-rChIL-2.
2.8. Phagocytosis assay
Phagocytosis of unopsonized SE by the heterophils
was determined by using duplicate, sterile 15 ml
polypropylene screw-capped centrifuge tubes that
contained 2 £ 106 heterophils (500 ml) and 2 £ 107
bacteria (200 ml) in a total volume of 1 ml RPMI 1640
as described [25]. The tubes were centrifuged (450g,
15 min, room temperature) in order to maximize
contact between heterophils and bacteria. The cells
were then allowed to incubate at 39 8C for 30 min on a
rotary shaker to allow for phagocytosis. After each
incubation period, the tubes were placed on ice to stop
phagocytosis. The cells were washed three times with
ice-cold RPMI 1640, centrifuged, and resuspended in
1 ml cold RPMI 1640. Cytospin smears were then
prepared from each tube, stained with Hema-3, and
examined by light microscopy with the oil immersion
objective (100 £ ).
An individual unaware of the groups performed all
counts. At least 100 heterophils on each slide were
scored for the percentage of heterophils that contained
bacteria and for the number of bacteria associated
with each heterophil. The results are expressed as the
percentage of heterophils that contain bacteria, the
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average number of bacteria per ingesting heterophil,
and the phagocytic index (PI), where PI ¼
(percentage of heterophils that contain bacteria £ the
average number of bacteria per ingesting
heterophil) £ 100.
2.9. Bactericidal assay
The bactericidal activity of peripheral blood
heterophils in 96-well microtiter plates was evaluated
as described previously [25]. Briefly, 1 £ 106 SE
(100 ml) were added to quadruplicate wells containing
2 £ 105 heterophils (100-ml of 2 £ 106 cells/ml sus-
pension). Control wells contained HBSS alone. In
addition, a suspension of 2 £ 107 bacteria (100%) in
HBSS was diluted to 70, 40, and 10% of this
concentration, and 100-ml amounts of each dilution
were added to quadruplicate wells for the construction
of a standard curve. The plates were centrifuged (400g
for 5 min at 4 8C) to allow maximum bacteria/
heterophil contact. At this moment, one plate was
removed, the heterophils lysed, and the number of
bacteria determined using the XTT assay as described
below. This was considered to be the time ¼ 0 time
point. The remaining plates were then incubated for
either 30 or 60 min at 37 8C. After this incubation, the
heterophils were lysed by adding 50 ml of 0.1% Triton
X-100. Fifty microliters of 3,30-[1[(phenylamino)car-
bonyl]-3,4-tetrazolium]-bis(4-methoxy-6-nitro) ben-
zene sulfonic acid hydrate (XTT, 0.5 mg/ml; Sigma
Chemical Co., St Louis, MO) containing 40 mg/ml of
2,3-dimethoxy-5-methyl-1,4-benzoquinone (coen-
zyme Q, CQ; Sigma Chemical Co., St Louis, MO)
were added to each well and the plates were returned
to the incubator for 30 min to allow the viable bacteria
to reduce the XTT to formazan. The soluble formazan
produced by the bacteria was then quantitated by
measuring the optical densities of each well at 450 nm
with an automated ELISA plate reader (Bio-Tek,
Model EL 311, Winooski, VT). Bactericidal activity
of the test wells was extrapolated from a standard
curve generated using known bacterial concen-
trations. Each plate was compared to its own standard
curve to account for day-to-day and plate-to-plate
variations. The standard curve was verified by
standard plate counts. The results are expressed as
the percent bacterial killing.
2.10. Oxidative burst
The oxidative burst of the rChIL-2-treated chicken
heterophils was measured by luminol-dependent
chemiluminescence (LDCL). One hundred microli-
ters of heterophils (4 £ 106 cells/ml), 100 ml of OZ
(20 mg/ml), and 500 ml of luminol (0.1 M in RPMI
1640) were placed in each Beckman polypropylene
scintillation vial and incubated at room temperature
for 30 min. The LDCL was measured in a LKB 1219
series liquid scintillation counter using the tritium
channel and the coincidence mode. LDCL was
quantified as cpm. All samples were assayed in
replicates of five vials. Results are expressed as
cpm/106 heterophils.
2.11. Degranulation
Degranulation was detected by quantifying the
amount of b-D-glucuronidase activity in the culture
medium following stimulation of the heterophils
with OZ. Heterophils (8 £ 106 ml21) were pre-
treated with either rChIL-2 or supernatants from
mock-transfected COS cells and then incubated
with OZ (2 mg/ml) for 1 h at 39 8C on a rotary
shaker in a 5% CO2 incubator. The reaction was
stopped by transferring the tubes containing the
cells to an ice bath for 5–10 min. The cells were
then centrifuged at 250g for 10 min at 4 8C. The
supernatants were then removed and used for the
assay. Samples (25 ml) of each supernatant were
added to quadruplicate wells in a non-treated
black CoStar flat-bottom ELISA plate and incu-
bated with 50 ml of freshly prepared substrate
(10 mM 4-methylumbelliferyl-b-D-glucuronide,
0.1% Triton X-100 in 0.1 M sodium acetate
buffer) for 4 h at 41 8C. The reaction was stopped
by adding 200 ml of a stop solution (0.05 M
glycine and 5 mM EDTA; pH 10.4). Liberated 4-
methylumbelliferone was measured fluorimetri-
cally (excitation wavelength of 355 nm and an
emission wavelength of 460 nm) with a fmax
fluorescence microplate reader (Molecular
Devices, Sunnyvale, CA). These values were
converted to nanomoles of 4-methylumbelliferone
generated using a standard curve of known
concentrations of 4-methylumbelliferone.
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2.12. Statistical analysis
The mean and standard error of the mean were
calculated for each of the treatment groups in each of
the heterophil functional assays. Functional differ-
ences between the rChIL-2-treated and the mock
transfectant control supernatant-treated control cells
were determined by analysis of variance. Significant
differences were further separated using Duncan’s
multiple range test. The data are presented in all
figures and tables as mean ^ SEM.
3. Results
3.1. Phagocytosis
The ability of avian heterophils preincubated with
rChIL-2 to phagocytize non-opsonized SE was
determined and the experiments are summarized in
Table 1. ChIL-2 had no effect on phagocytosis by
heterophils isolated from day-of-hatch chicks. Het-
erophils isolated from chicks 7- and 14-days post-
hatch primed with the 1:100 or 1:1000 dilution of
ChIL-2 exhibited significantly ( p , 0.01) greater
phagocytic activity as compared to the cells treated
with the supernatants from the mock-transfected COS
cells. This phagocytic activity was concentration-
dependent and manifested by both an increase in the
percentage of heterophils that phagocytized SE and an
increase in the number of bacteria that were engulfed
by each heterophil.
3.2. Bacterial killing
The effects of rChIL-2 on the bactericidal activity
of heterophils isolated from chicks at day-of-hatch, 7-
or 14-days after hatch are shown in Fig. 1. rChIL-2
pretreatment had no significant effect on the bacteri-
cidal activity of heterophils from the day-of-hatch
chicks increasing the killing activity of the cells by
less than 5% regardless of the concentration of
cytokine used. However, rChIL-2 pretreatment of
the heterophils from 7- and 14-day-old chicks induced
a significant ( p , 0.01) concentration-dependent
increase in bacterial killing ability. Depending upon
concentration of the cytokine, bactericidal activityT
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was increased from 22 to 50% over the supernatants
from the mock transfectant-treated heterophils.
3.3. Oxidative burst
The effects of rChIL-2 on the oxidative burst
generated by heterophils isolated from chicks at
different days post-hatch are shown in Table 2.
Treatment of the heterophils with the rChIL-2 did
not directly stimulate an oxidative burst. Likewise,
rChIL-2 treatment of heterophils from day-of-hatch
chicks had no priming effect on the PMA-induced
oxidative burst. However, treatment of heterophils
from 7- and 14-day old chicks with rChIL-2 primed
the cells for at least a 2-fold increase ( p , 0.01) in
PMA-induced oxidative burst as compared to the
Fig. 1. Bactericidal activity of heterophils isolated from chickens at 1-, 7-, and 14-days post-hatch. Heterophils were pretreated with various
dilutions of COS cell-derived rChIL-2 for 2 h 39 8C as described in Section 2. The data points with asterisks indicate a significant increase in
heterophil bactericidal activity, when compared to the age-matched heterophils pretreated with mock-transfected COS cell supernatants. Data
presented as mean ^ SEM.
Table 2
Effect of recombinant chicken IL-2 on oxidative burst generated by heterophils isolated from chicks at different ages
Age (days) PMAa Chemiluminescence; peak cpm ( £ 106); dilution of rChIL-2 (log 10)
0b 100 1000 10,000
1 2 0.49 ^ 0.11 0.51 ^ 0.09 0.49 ^ 0.10 0.48 ^ 0.13
þ 9.9 ^ 1.5 9.6 ^ 1.8 9.9 ^ 1.9 8.3 ^ 1.2
7 2 2.30 ^ 0.62 2.05 ^ 0.43 1.83 ^ 0.44 2.22 ^ 0.31
þ 14.4 ^ 1.7 29.1 ^ 3.0* 24.3 ^ 2.2* 12.6 ^ 2.1
14 2 3.41 ^ 0.33 3.2 ^ 0.3 3.9 ^ 0.2 4.1 ^ 0.6
þ 14.7 ^ 2.2 36.8 ^ 4.4* 39.6 ^ 3.4* 18.9 ^ 1.3
Within rows, numbers with * are significantly different from their age-matched control heterophils.
a Heterophils either non-stimulated or stimulated with 2 mg/ml PMA.
b Mock transfectant control (1:100 dilution).
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age-matched control heterophils treated with super-
natants from the mock-transfected COS cells.
3.4. Degranulation
Treatment of heterophils from any age chicks with
either rChIL-2 or supernatants from the mock
transfected COS cells did not induce the direct release
of the primary granule, b-D-glucuronidase (Table 3).
Interestingly, treatment of the heterophils isolated
from any age chick with rChIL-2 did not induce a
significantly different priming response to OZ as
compared to the supernatants from the mock-
transfected COS cells.
3.5. mAb neutralization—phagocytosis
Treatment of rChIL-2 (1:100 dilution of stock
supernatant) with 4F12 specifically neutralized the
rChIL-2-mediated increase in phagocytosis by hetero-
phils isolated from 7- and 14-day-old chicks (Fig. 2A
and B). Pretreatment of the rChIL-2 with the control
murine IgG had no neutralizing activity on
phagocytosis.
3.6. mAb neutralization—bacterial killing
Treatment of rChIL-2 with 4F12 specifically
neutralized all of the rChIL-2-mediated increase in
bactericidal activity by heterophils from either 7- or
14-day-old chicks (Fig. 3A and B). Pretreatment of
the rChIL-2 with the control murine IgG had no
neutralizing action on the killing activity by the
heterophils.
3.7. mAb neutralization—oxidative burst
The monoclonal antibody, 4F12, specifically
neutralized all of the rChIL-2-mediated priming of
the PMA-induced oxidative burst by the heterophils
from 7- and 14-day-old chicks (Fig. 4A and B) while
the control murine IgG had no neutralizing effect on
heterophil priming.
4. Discussion
We have previously demonstrated that undefined T
cell supernatants can enhance the functional capabili-
ties of these neonatal poultry heterophils to mimic the
function of heterophils from mature birds [2,25,28].
Furthermore, we have shown a correlation between
the enhancement of heterophil function in vitro with
an increase in host resistance to Salmonella infections
in vivo [25]. We also found that rChIFN-g is capable
of enhancing the functional efficiency of heterophils
from neonatal chickens [30].
Long thought to be a growth factor primarily
involved in the activation of B and T lymphocytes
[12,13,30,31], IL-2 has proven to be a much more
pleiotropic cytokine. Evidence from recent years has
shown that IL-2 plays a critical role in cells specifically
involved in the innate immune responses including NK
cells, monocytes, eosinophils, and neutrophils [14–23].
Furthermore, IL-2 has been shown to modulate the
Table 3
Effect of recombinant chicken IL-2 on degranulation by heterophils isolated from chicks at different ages
Age (days) OZa mM b-D-glucuronidase released; dilution of rChIL-2 (log 10)
0b 100 1000 10,000
1 2 1.83 ^ 0.32 1.76 ^ 0.39 1.72 ^ 0.67 1.56 ^ 0.41
þ 12.91 ^ 2.12 11.98 ^ 1.83 12.11 ^ 2.17 12.05 ^ 1.92
7 2 2.64 ^ 0.77 2.80 ^ 0.48 2.76 ^ 0.51 2.56 ^ 0.87
þ 12.21 ^ 1.98 12.05 ^ 2.11 12.47 ^ 1.23 13.43 ^ 2.76
14 2 6.53 ^ 2.19 6.55 ^ 1.78 7.13 ^ 1.69 6.77 ^ 1.49
þ 16.44 ^ 3.12 15.23 ^ 1.11 14.59 ^ 1.77 13.14 ^ 2.21
Within rows, numbers with * are significantly different from their age-matched control heterophils.
a Heterophils either non-stimulated or stimulated with 2 mg/ml OZ.
b Mock transfectant control (1:100 dilution).
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Fig. 2. Effect of mAb (4F12) pretreatment of COS-cell-derived rChIL-2 on phagocytosis of non-opsonized SE by heterophils isolated from
chickens 7- and 14-days post-hatch (A and B, respectively). The COS cell-derived rChIL-2 was pretreated with 4F12 as described in Section 2.
Bars with asterisks indicate a significant increase in phagocytosis from age-matched heterophils incubated for 2 h with 4F12-treated rChIL-2.
Data presented as mean ^ SEM.
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Fig. 3. Effect of mAb (4F12) pretreatment of COS cell-derived rChIL-2 on the bactericidal activity of heterophils isolated from chickens 7- or
14-days post-hatch (A and B, respectively). The COS cell-derived rChIL-2 was pretreated with 4F12 as described in Section 2. Bars with
asterisks indicate a significant increase in bactericidal activity from age-matched heterophils incubated for 2 h with 4F12-treated rChIL-2. Data
presented as mean ^ SEM.
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Fig. 4. Effect of mAb (4F12) pretreatment of COS cell-derived rChIL-2 on the respiratory burst of heterophils isolated from chickens 7- or 14-
days post-hatch (A and B, respectively). The COS cell-derived rChIL-2 was pretreated with 4F12 as described in Section 2. Bars with asterisks
indicate a statistically significant increase in respiratory burst from age-matched heterophils incubated for 2 h with 4F12-treated rChIL-2. Data
presented as mean ^ SEM.
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function of intestinal epithelial cells [32,33]. Here, we
provide evidence that IL-2 from chickens can upregu-
late certain functions of the heterophil.
IL-2 binds to specific cell receptors. In mammals,
IL-2 receptors (IL-2R) are composed of at least three
subunits, a-, b-, and g-chains [34,35]. The b and g
chains have intermediate binding affinity and mediate
many of the biological activities of IL-2. IL-2Rb and
IL-2Rg are constitutively expressed on neutrophils
[15,16]; whereas, IL-2Ra is absent [15]. The avian IL-
2R has not been well characterized, although a mAb
thought to recognize the avian IL-2R a-chain has been
developed [36,37]. Using this mAb against the avian
IL-2Ra chain, we could not block the functional
activation of heterophils induced by the rChIL-2 (data
not shown). However, an anti-rChIL-2R mAb neu-
tralized IL-2-mediated functional activation. It is
therefore reasonable to speculate that the avian
heterophil may also constitutively express IL-2Rb
and g. However, until more tools are developed for
chicken IL-2 receptors, this remains speculation on
our part.
In this study, rChIL-2 significantly increased
phagocytic activity in avian heterophils when com-
pared to the effect of mock-transfected cell super-
natants (Table 1). Definitive proof that IL-2 was
inducing the enhanced phagocytosis was obtained by
the ability of the specific anti-ChIL-2 mAb to abrogate
the phagocytic activity of the cells. These results
differ from those observed with IL-2-treated mamma-
lian neutrophils where the cytokine had no effect on
the phagocytic activity of these granulocytic cells [38,
39]. While at this time we have no explanation for the
apparent difference in IL-2-mediated enhancement of
phagocytosis between mammalian neutrophils and
avian heterophils, it can be pointed out that our
phagocytosis experiments were conducted without
opsonizing the bacteria. Therefore, we can eliminate
both Fc and complement receptor involvement in the
IL-2-mediated increase in phagocytosis since one
mechanism of phagocytosis is triggered through
receptors for opsonized particles. In contrast, opso-
nin-independent phagocytosis, as described here, is
mediated by receptors on the plasma membranes of
the phagocyte that directly recognize ligands on the
surfaces of the microbe [40]. These cellular receptors
are members of a family of germ-line encoded
molecules titled pattern recognition receptors
(PRRs) that recognize conserved motifs (pathogen
recognition molecular patterns, PAMPs) on the
microbial pathogens that are not found in eukaroytes
[41]. These PRRs include surface molecules such as
mannose and scavenger receptors [42–44]. Both
mannose and scavenger receptor expression and
activity are regulated by cytokines [45–47]. It is
possible that the IL-2-mediated increase in phagocy-
tosis observed in these studies resulted from an
increased expression and/or activity of mannose or
scavenger receptors. Further experiments are pre-
sently underway to confirm this hypothesis.
Following phagocytosis, we demonstrated that
treatment of the heterophils with rChIL-2 enhanced
the bactericidal activity of the cells (Fig. 3) and that
this activity was also neutralized by the anti-ChIL-
2mAb. Two bactericidal processes are available to the
heterophil: the oxidative burst or the release of lytic
enzymes and anti-microbial peptides from intracellu-
lar granules (degranulation). Analysis of the mechan-
ism of bacterial killing by IL-2-stimulated heterophils
indicated that degranulation was not involved as
shown by both the lack of b-D-glucuronidase release
following by IL-2 treatment and the inability of IL-2
to prime the heterophil for b-D-glucuronidase release
by zymosan stimulation. In contrast, IL-2 was a potent
primer of the heterophils for an increased oxidative
burst upon stimulation with PMA (Tables 2 and 3),
which was inhibited following treatment with the anti-
rChIL-2 mAB, 4F12 (Fig. 4). IL-2 had no direct
stimulatory activity on the heterophil oxidative burst.
These results are in direct contrast to those found with
IL-2 treatment of mammalian neutrophils where IL-2
had no effect on the generation of an oxidative burst
[39], but primes the cells for increased release of the
granule lactoferrin [15]. It remains to be determined
why the response of avian heterophils to IL-2 is
different then the response of mammalian neutrophils.
We have shown previously that rChIFN-g is a potent
priming agent for both anti-microbial killing mech-
anisms of avian heterophils [30]. Interestingly, we
found that rChIFN-g is capable of enhancing the
functional efficiency of heterophils from day-old
chickens. These results were in agreement with
mammalian studies that demonstrated that cytokines
have a more profound effect on neutrophils with
depressed function than on normal neutrophils [48].
Taken together, the results from the present studies
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suggest that IL-2 may play a very specialized role in a
critical function of avian heterophils; i.e. oxygen-
dependent anti-microbial activity, at a time post-hatch
(by 7 days) that initiates the onset of measurable
specific acquired immunity to vaccines given in ovo
or immediately post-hatch [49]. We can speculate that
IL-2, produced during the activation of T lympho-
cytes, could be functioning not only as a T cell growth
factor, but also as a supplemental heterophil-activat-
ing agent. Therefore, we propose that the biological
effects of IL-2 in birds could be extended to include a
supporting role in heterophil-mediated innate immune
responses.
The present report demonstrates that IL-2 plays a
role in heterophil activation. The data define a new
pathway where IL-2 can augment acute inflammation
by supporting both phagocytosis and oxidative burst.
Taken together with our previous reports that hetero-
phils can respond to rChIFN-g and non-specific T-cell
lymphokines with increased phagocytosis and bac-
terial killing [23,25,29,30], the data suggest that
heterophils possess many cytokine receptors; and
thus, are able to respond rapidly and efficiently to
inflammatory mediators triggered by the invasion of
mucosal surfaces by pathogenic microorganisms. Our
data certainly support the view that the biologic
effects of IL-2 extend beyond T- and B-cell growth
promotion and activation to include a role in
developing heterophil-mediated innate immunity.
This study does not address the question of the in
situ source of IL-2. Although systemically produced
IL-2 could possibly be involved in heterophil
activation, we support the hypothesis that local
production of IL-2 plays a more active role in
supplementing heterophil activation during acute
inflammation. For example, in response to pathogen
invasion in the intestine, IL-2 is produced by
subpopulations of T cells that reside within the
intestinal epithelium of both mammals and chickens
[50–56]. The IL-2 produced by these intraepithelial
lymphocytes (IELs) promotes epithelial wound heal-
ing [51] and the growth and effector function
differentiation of all IEL subpopulations [54,56].
Likewise, bacterial invasion of the mucosal epi-
thelium stimulates the production of IL-8, which is
responsible for the recruitment of granulocytic cells to
the local site of inflammation [57,58]. In chickens,
intestinal invasion by paratyphoid Salmonella stimu-
late a strong acute inflammatory response mediated by
the differential expression and production of inflam-
matory cytokines and the migration of heterophils to
the local site of invasion [59]. Therefore, both
heterophils and IL-2 are present locally.
In summary, we have provided data that demon-
strates ChIL-2 is capable of augmenting certain
functional activities of chicken heterophils. This
heterophil activation is an age-dependent event since
heterophils from day-old chickens are not responsive
to the ChIL-2. The effects of IL-2 on heterophils were
specific because a neutralizing anti-ChIL-2 mAb
completely inhibited the functional activation of the
heterophils. These results illustrate that ChIL-2 is
more pleiotropic than believed since it can directly
activate chicken heterophils to exert effector
functions.
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